Advanced search
Publication Cover
Australasian Psychiatry Volume 13, 2005 - Issue 1
Journal homepage
64
Views
8
CrossRef citations to date
0
Altmetric
EATING DISORDERS

Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa

Naresh Mondraty Peter Beumont Eating Disorder Service, Ashfield, NSW, AustraliaCorrespondence[email protected]
,
C. Laird Birmingham Eating Disorders Programme, St Paul's Hospital, University of British, Columbia, Vancouver, Canada
,
Stephen Touyz School of Psychology, University of Sydney, NSW, Australia
,
Viktoria Sundakov Royal Prince Alfred Hospital, Central Sydney Area Health Service, Sydney, NSW, Australia
,
Lucy Chapman Royal Prince Alfred Hospital, Central Sydney Area Health Service, Sydney, NSW, Australia
&
Pierre Beumont Discipline of Psychological Medicine, University of Sydney and Royal Prince Alfred Hospital, NSW, Australia
Pages 72-75 | Published online: 16 Sep 2009

REFERENCES

  • Sunday S, Halmi K, Einhorn A. The Yale-Brown-Cornell Eating Disorder Scale: a new scale to assess eating disorder symptomatology. International Journal of Eating Disorders 1995; 18: 237–245
  • Herzog D B, Nussbaum K M, Marmor A K. Comorbidity and outcome in the eating disorders. Psychiatric Clinics of North America 1996; 19: 842–859
  • Attia E, Mayer L, Killory J. Medication response in the treatment of patients with anorexia nervosa. Journal of Psychiatric Practice 2001; 7: 157–162
  • Ferguson C, Pigott T. Anorexia and bulimia nervosa. Neurobiology and pharmacotherapy. Behaviour Therapy 2000; 31: 237–263
  • Powers P, Santana C, Bannon Y. Olanzapine in the treatment of anorexia nervosa: an open label trial. International Journal of Eating Disorders 2002; 32: 146–154
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC 1994
  • Garner D. Eating Disorder lnventory-2: Professional Manual. Psychological Assessment Resources, OdessaFL, USA 1991
  • Sanavio E. Obsessions and compulsions. The Padua Inventory. Behaviour Research Therapeutics 1988; 1: 169–177
  • Ames D, Camm J, Johnson G. Minimizing the risks associated with significant QTc prolongation in people with schizophrenia: a consensus statement by the Cardiac Safety in Schizophrenia Group. Australasian Psychiatry 2002; 10: 115–124

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.